A5064690210- Diabetes Management and Research
- Cardiovascular Health and Disease Prevention
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Disease and Adiposity
- Adipokines, Inflammation, and Metabolic Diseases
- Nutritional Studies and Diet
- Diabetes Treatment and Management
- Natural Antidiabetic Agents Studies
- Diabetes and associated disorders
- Genetic Associations and Epidemiology
Universidad Tecnológica de Aguascalientes
2019
Hypertension is associated with insulin resistance (IR), metabolic syndrome (MS), and arterial stiffness. Non-insulin-based IR indexes were developed as tools for screening. Here, we aimed to evaluate the novel non-insulin-based Metabolic Score (METS-IR) index prediction of incident hypertension stiffness evaluated using pulse wave velocity (PWV) analysis, compared other indexes. We two populations, a cross-sectional evaluation high-risk individuals (n = 305) wide range comorbidities...
Type 2 diabetes mellitus (T2D) is a leading cause of morbidity and mortality in Mexico. Here, we aimed to report incidence rates (IR) type middle-aged apparently-healthy Mexican adults, identify risk factors associated ID develop predictive model for high-risk population.Prospective 3-year observational cohort, comprised adults from urban settings central Mexico whom demographic, anthropometric biochemical data was collected. We evaluated using Cox proportional hazard regression developed...
Abstract Aims This subanalysis of the SoliMix trial assessed efficacy and safety advancing basal insulin (BI) therapy with iGlarLixi versus BIAsp 30 in people type 2 diabetes (T2D) living Latin American (LATAM) countries, i.e. Argentina Mexico ( N = 160). Materials Methods (EudraCT: 2017‐003370‐13) was a 26‐week, open‐label, multicentre study, where adults T2D suboptimally controlled BI plus one or two oral glucose‐lowering drugs glycated haemoglobin (HbA1c) ≥7.5% to ≤10% were randomized...